Insider Actions for Biogen Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 09/05/2023 |
Priya Singhal Head of Development |
431 | Disposition at $269.43 per share. | 116,124 |
| 09/01/2023 |
Michael R. McDonnell EVP, Chief Financial Officer |
1,332 | Derivative/Non-derivative trans. at $267.17 per share. | 355,870 |
| 09/01/2023 |
Michael R. McDonnell EVP, Chief Financial Officer |
1,372 | Derivative/Non-derivative trans. at $267.17 per share. | 366,557 |
| 09/01/2023 |
Priya Singhal Head of Development |
807 | Derivative/Non-derivative trans. at $267.17 per share. | 215,606 |
| 09/01/2023 |
Michael R. McDonnell EVP, Chief Financial Officer |
2,603 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 09/01/2023 |
Michael R. McDonnell EVP, Chief Financial Officer |
2,682 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 09/01/2023 |
Priya Singhal Head of Development |
1,668 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 07/03/2023 |
Priya Singhal Head of Development |
81 | Disposition at $282.87 per share. | 22,912 |
| 06/30/2023 |
Rachid Izzar Head of Global Product Strat. |
244 | Derivative/Non-derivative trans. at $284.85 per share. | 69,503 |
| 06/30/2023 |
Robin C. Kramer Chief Accounting Officer |
122 | Derivative/Non-derivative trans. at $284.85 per share. | 34,751 |
| 06/30/2023 |
Priya Singhal Head of Development |
153 | Derivative/Non-derivative trans. at $284.85 per share. | 43,582 |
| 06/30/2023 |
Rachid Izzar Head of Global Product Strat. |
504 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/30/2023 |
Robin C. Kramer Chief Accounting Officer |
252 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/30/2023 |
Priya Singhal Head of Development |
315 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/26/2023 |
Caroline D. Dorsa Director |
1,580 | Award at $0 per share. | 0 |
| 06/26/2023 |
Eric K. Rowinsky Director |
960 | Award at $0 per share. | 0 |
| 06/26/2023 |
Stephen A. Sherwin Director |
960 | Award at $0 per share. | 0 |
| 06/26/2023 |
Jesus B. Mantas Director |
960 | Award at $0 per share. | 0 |
| 06/26/2023 |
William A. Hawkins Director |
960 | Award at $0 per share. | 0 |
| 06/26/2023 |
Maria C. Freire Director |
960 | Award at $0 per share. | 0 |
| 06/26/2023 |
Susan Langer Director |
960 | Award at $0 per share. | 0 |
| 04/28/2023 |
Ginger Gregory EVP, Human Resources |
2,681 | Disposition at $300 per share. | 804,300 |
| 04/04/2023 |
Priya Singhal Head of Development |
91 | Disposition at $277.11 per share. | 25,217 |
| 03/31/2023 |
Nicole Murphy Head of Pharm Ops and Tech |
116 | Derivative/Non-derivative trans. at $278.03 per share. | 32,251 |
| 03/31/2023 |
Nicole Murphy Head of Pharm Ops and Tech |
239 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/28/2023 |
Priya Singhal Head of Development |
568 | Disposition at $270.06 per share. | 153,394 |
| 03/02/2023 |
Priya Singhal Head of Development |
144 | Derivative/Non-derivative trans. at $268.75 per share. | 38,700 |
| 03/02/2023 |
Priya Singhal Head of Development |
543 | Derivative/Non-derivative trans. at $268.75 per share. | 145,931 |
| 03/02/2023 |
Priya Singhal Head of Development |
297 | Derivative/Non-derivative trans. at $0 per share. | 0 |
